Title: Pharmaceutical Chemistry in Iraq. recent research topics and drug industry

Biography:

Kafa Khalaf Hammud has completed her BSC, MSC, and PhD from Department of Chemistry, College of Science, Baghdad University, Iraq. She works at Directorate of Materials Research, Ministry of Science & Technology. She has published several scientific articles and has been serving as an editorial board member. Her main concern related to chemistry subjects such as synthesis, characterization and application. 

Abstract

This paper gave a mini review about pharmaceutical chemistry that started from lab experiments and end at publication stage but not at industry stage. There are many scientific paper that deal with new organic or organometallic compounds with good biological activities. These compounds are differing in their structures and methods of preparation beside the prior biological activities. The biological applications are mostly limited as antibacterial or antifungal agents at agar plates and may be solely increased to mice tests. These preparation and biological steps were dependant on the presence of functional groups or heteroatoms. So, Iraqi researchers as students or supervisors synthesized and characterized a large number of derivatives with no happy ending as a drug or treatment. This problem is present in medicinal herbs plant in Iraq. Many research papers about herbal extracts end at bacterial or fungal tests and may moved another step with cancer cell line then nothing more. In Iraq, there are the state company for drugs industry in Samarra (SDI) and other state in Nineveh (NDI). Both states are authorized for production of specific drugs such as antibiotics but not for new synthesized compounds might be a promising therapy. The Iraqi private drugs companies are limited in their choices and do not support such issue. For this case, I do think that solutions for this issue are related to main drug and disease relationship. In another words, we want a drug to treat a disease and industry need scientific documentations describes all pharmaceutical requirements and solution begins by supporting known companies searching of truth in facilitated labs.